Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-24-037823
Filing Date
2024-09-23
Accepted
2024-09-23 16:48:16
Documents
28
Period of Report
2024-09-23

Document Format Files

Seq Description Document Type Size
1 pre14a.htm PRE 14A 6380898
2 image_002.jpg GRAPHIC 1128
3 image_003.jpg GRAPHIC 1094
4 image_004.jpg GRAPHIC 1133
5 pre14a_01.jpg GRAPHIC 108874
6 pre14a_03.jpg GRAPHIC 30051
7 image_007.jpg GRAPHIC 717
8 image_008.jpg GRAPHIC 718
9 image_009.jpg GRAPHIC 45718
10 image_010.jpg GRAPHIC 64146
11 image_011.jpg GRAPHIC 154331
12 image_012.jpg GRAPHIC 76642
13 image_013.jpg GRAPHIC 1118
14 image_014.jpg GRAPHIC 660
15 image_015.jpg GRAPHIC 1112
16 image_016.jpg GRAPHIC 1075
17 image_017.jpg GRAPHIC 363
18 image_018.jpg GRAPHIC 1065
19 image_019.jpg GRAPHIC 659
20 image_020.jpg GRAPHIC 1056
21 image_021.jpg GRAPHIC 363
22 image_022.jpg GRAPHIC 18430
23 image_023.jpg GRAPHIC 4903
24 image_024.jpg GRAPHIC 3918
25 image_025.jpg GRAPHIC 4368
26 image_026.jpg GRAPHIC 4089
27 image_027.jpg GRAPHIC 4169
28 image_029.jpg GRAPHIC 4016
  Complete submission text file 0001493152-24-037823.txt   7123107
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

EIN.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36754 | Film No.: 241316711
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)